Fig. 4

Survival analyses for C20orf54 expression and other clinical parameters in ESCC patients. The Kaplan-Meier survival curves that show the association among ESCC patient survival times with the C20orf54 expression level (A, P = 0.068), differentiation (B, P = 0.213), L/N metastasis (C, P = 0.001), TNM stage (D, P = 0.007), invasion depth (E, P = 0.001), location (F, P = 0.031), smoking status (G, P = 0.906), and drinking status (H, P = 0.715)